Attached files
| file | filename |
|---|---|
| EX-3.3 - EX-3.3 - Viamet Pharmaceuticals Holdings LLC | d721802dex33.htm |
| EX-4.1 - EX-4.1 - Viamet Pharmaceuticals Holdings LLC | d721802dex41.htm |
| EX-10.11 - EX-10.11 - Viamet Pharmaceuticals Holdings LLC | d721802dex1011.htm |
| S-1 - FROM S-1 - Viamet Pharmaceuticals Holdings LLC | d721802ds1.htm |
| EX-10.2 - EX-10.2 - Viamet Pharmaceuticals Holdings LLC | d721802dex102.htm |
| EX-10.10 - EX-10.10 - Viamet Pharmaceuticals Holdings LLC | d721802dex1010.htm |
| EX-10.8 - EX-10.8 - Viamet Pharmaceuticals Holdings LLC | d721802dex108.htm |
| EX-3.2 - EX-3.2 - Viamet Pharmaceuticals Holdings LLC | d721802dex32.htm |
| EX-10.3 - EX-10.3 - Viamet Pharmaceuticals Holdings LLC | d721802dex103.htm |
| EX-10.4 - EX-10.4 - Viamet Pharmaceuticals Holdings LLC | d721802dex104.htm |
| EX-10.5 - EX-10.5 - Viamet Pharmaceuticals Holdings LLC | d721802dex105.htm |
| EX-3.4 - EX-3.4 - Viamet Pharmaceuticals Holdings LLC | d721802dex34.htm |
| EX-23.3 - EX-23.3 - Viamet Pharmaceuticals Holdings LLC | d721802dex233.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 23, 2014, (except Note , as to which the date is , 2014), in the Registration Statement (Form S-1 No. 333- ) and related Prospectus of Viamet Pharmaceuticals Holdings, LLC for the registration of shares of its common stock.
Ernst & Young LLP
Raleigh, North Carolina
The foregoing consent is in the form that will be signed upon the completion of the reverse stock split described in Note to the financial statements.
/s/ Ernst & Young LLP
Raleigh, North Carolina
June 30, 2014